543 0 Kommentare Horizon Technology Finance Leads $10 Million Venture Loan for IntegenX

FARMINGTON, CT and PLEASANTON, CA--(Marketwired - Sep 22, 2014) - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a $10 million venture loan for IntegenX Inc. ("IntegenX"), the market leader in Rapid Human DNA identification technology. The venture loan was fully funded at closing, with Horizon, Square 1 Bank and a third lender funding their commitments of $3.75 million, $2.5 million, and $3.75 million, respectively. IntegenX will use the funds primarily for working capital purposes.

"We are pleased to lead a $10 million venture loan for IntegenX, an exciting company at the forefront of using technology to improve the ease and speed of DNA testing while reducing its cost," stated Gerald A. Michaud, President of Horizon. "IntegenX's focus on forensics applications that have high growth potential, its impressive customer traction and its strong position in international markets, makes IntegenX another compelling company in our high quality investment portfolio."

Long

96,07€

Basispreis

1,16

Ask

× 7,54

Hebel

Zum Produkt

Short

118,93€

Basispreis

1,23

Ask

× 7,10

Hebel

Zum Produkt

Präsentiert von

Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

David V. Smith, Chief Operating Officer of IntegenX, stated, "The loan led by Horizon significantly increases our financial flexibility and positions us to build off of our domestic and international market momentum to ramp sales of our RapidHIT™ System. Horizon proved why it has a leading industry reputation as a venture lender through its ability to provide IntegenX with a tailored solution to meet its funding needs."

About Horizon Technology Finance
Horizon Technology Finance Corporation is a business development company that provides secured loans to development-stage companies backed by established venture capital and private equity firms within the technology, life science, healthcare information and services, and cleantech industries. The investment objective of Horizon is to maximize total returns by generating current income from a portfolio of directly originated secured loans as well as capital appreciation from warrants that it receives when making such loans. Headquartered in Farmington, Connecticut, with regional offices in Walnut Creek, California and Reston, Virginia, Horizon is externally managed by its investment advisor, Horizon Technology Finance Management LLC. Horizon's common stock trades on the NASDAQ Global Select Market under the ticker symbol "HRZN". In addition, Horizon's 7.375% 2019 Notes trade on the New York Stock Exchange under the ticker symbol "HTF." To learn more, please visit www.horizontechnologyfinancecorp.com.